Claus, B. B., Specka, M., McAnally, H., Scherbaum, N., Schifano, F., & Bonnet, U. (2020). Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor? Front Psychiatry.

Claus, Benedikt Bernd, Michael Specka, Heath McAnally, Norbert Scherbaum, Fabrizio Schifano, and Udo Bonnet. "Is the Urine Cannabinoid Level Measured Via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?" Front Psychiatry 2020.

Claus, Benedikt Bernd, et al. "Is the Urine Cannabinoid Level Measured Via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?" Front Psychiatry 2020.